Clinical Trials Directory

Trials / Completed

CompletedNCT02601287

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a safety and efficacy study of BOTOX® (Botulinum Toxin Type A) in the Treatment of Adult Korean Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity or Overactive Bladder.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBotulinum Toxin Type ABotulinum Toxin Type A into detrusor muscle on Day 1

Timeline

Start date
2015-11-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-11-10
Last updated
2016-07-21

Locations

5 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02601287. Inclusion in this directory is not an endorsement.